The Chemotherapy/Radiation Balance in Advanced Hodgkin's Lymphoma: Overweight Which Side?
- 20 December 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (36), 9058-9062
- https://doi.org/10.1200/jco.2005.04.4644
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano LinfomiJournal of Clinical Oncology, 2005
- Role of Positron Emission Tomography in LymphomaJournal of Clinical Oncology, 2005
- Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Cancer: Past, Present, and FutureJNCI Journal of the National Cancer Institute, 2005
- ChlVPP/ABVVP, a first line ‘hybrid’ combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysisBritish Journal of Haematology, 2004
- Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trialAnnals of Oncology, 2004
- Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?Journal of Clinical Oncology, 2004
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003
- ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trialAnnals of Oncology, 2002
- Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?The Hematology Journal, 2000
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998